(MYOK) |
| 0 (0%) 10-09 22:52 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 262.80 |
| Resistance 1: | 225.00 |
| Pivot price: | 224.31 |
| Support 1: | 222.94 |
| Support 2: | 221.66 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -5.660 |
| Book Value | 15.850 |
| PEG Ratio | 0.00 |
| Gross Profit | -4.242 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -23.1 |
| Return on Equity (ttm) | -42.7 |
Company news
Wed, 13 Sep 2023
Plasmodium ARK2 and EB1 drive unconventional spindle dynamics, during chromosome segregation in sexual transmission stages - Nature
Tue, 27 Jun 2023
11 best new Instagram bakeries in Hong Kong for cakes, pastries and more - South China Morning Post
Fri, 30 Oct 2020
Bristol Myers Squibb: The MyoKardia Acquisition Was Not A Bad Idea - citybuzz
Mon, 19 Oct 2020
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors - GlobeNewswire
Mon, 12 Oct 2020
Morgan Stanley and J.P. Morgan Bullish on Bristol Myers Squibb following promising Zeposia Phase 3 Ulcerative Colitis Data - TheStreet
Mon, 05 Oct 2020
Bristol-Myers’ $13 Billion Deal for MyoKardia Spotlights Cardiac Drugs - Barron's
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
